氣喘病新藥好消息

The Guardian

Asthma treatment has barely changed over 20 years, but this new development opens up the possibility that the 250,000 people with this more severe form of the disease could now take a pill twice a day instead of relying on inhalers or steroids.

Asthma drug 'gamechanger' could revolutionise treatment

Fevipiprant trial indicates it could halve patients’ risk of suffering asthma attacks and being admitted to hospital

THEGUARDIAN.COM|由 DENIS CAMPBELL 上傳